$heff's $tation of $tocks & $olid DD

[biolover]

YMI- the CC was excellent . Definately gives you a closer perspective of jak inhibitors. As you point out Anaemia is the thing which will make it block buster and approvable in future . They have very strong patents. After people listens to CC they will realize what I am talking about . Anybody wanting to invest in YMI or is already invested should listen to Cc.

It's all about anemia and transfusion dependence, this is what separates this very specific Jak1/2 inhibitor (YMI) from others . I won't be surprised to see a partnership or buyout in near future .

Sheff , thanks for advise regarding analyst targets.